Molecular markers of injury in kidney biopsy specimens of patients with lupus nephritis

Journal of Molecular Diagnostics

Volumn 13, Issue 2, 2011, Pages 143-151

  Reich, Heather N ^a   Landolt Marticorena, Carol ^a   Boutros, Paul C ^b   John, Rohan ^a   Wither, Joan ^a   Fortin, Paul R ^a   Yang, Stuart ^a   Scholey, James W ^a   Herzenberg, Andrew M ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; MESSENGER RNA; MOLECULAR MARKER; PARAFFIN; RNA;

ARTICLE; CONTROLLED STUDY; GENE DUPLICATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION;

EID: 79952268053     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2010.10.005     Document Type: Article

References (37)

1. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Domenech I, Aydintug AO, Jedryka-Goral A: Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1993, 72:113-124
2. Alarcon GS, McGwin G Jr, Petri M, Reveille JD, Ramsey-Goldman R, Kimberly RP: Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 2002, 11:95-101 (Pubitemid 34259439)
3. Beimler JH, Andrassy K: Cyclophosphamide treatment in systemic necrotizing vasculitis and lupus nephritis. How long? How much? Pediatr Nephrol 2004, 19:949-955 (Pubitemid 39242773)
4. Shemesh O, Golbetz H, Kriss JP, Myers BD: Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985, 28:830-838 (Pubitemid 16156326)
5. Ju W, Eichinger F, Bitzer M, Oh J, McWeeney S, Berthier CC, Shedden K, Cohen CD, Henger A, Krick S, Kopp JB, Stoeckert CJ Jr, Dikman S, Schroppel B, Thomas DB, Schlondorff D, Kretzler M, Bottinger EP: Renal gene and protein expression signatures for prediction of kidney disease progression. Am J Pathol 2009, 174:2073-2085
6. Izmirly PM, Barisoni L, Buyon JP, Kim MY, Rivera TL, Schwartzman JS, Weisstuch JM, Liu DT, Bernstein S, Tseng CE, Belmont HM, Esmon CT, Merrill JT, Askanase AD, Thomas DB, Clancy RM: Expression of endothelial protein C receptor in cortical peritubular capillaries associates with a poor clinical response in lupus nephritis. Rheumatology (Oxford) 2009, 48:513-519
7. Cohen CD, Frach K, Schlondorff D, Kretzler M: Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. Kidney Int 2002, 61:133-140 (Pubitemid 34075139)
8. Kretzler M, Cohen CD, Doran P, Henger A, Madden S, Grone EF, Nelson PJ, Schlondorff D, Grone HJ: Repuncturing the renal biopsy: strategies for molecular diagnosis in nephrology. J Am Soc Nephrol 2002, 13:1961-1972 (Pubitemid 34700623)
9. Schmid H, Cohen CD, Henger A, Irrgang S, Schlondorff D, Kretzler M: Validation of endogenous controls for gene expression analysis in microdissected human renal biopsies Kidney Int 2003, 64:356-360
10. Schmid H, Cohen CD, Henger A, Schlondorff D, Kretzler M: Gene expression analysis in renal biopsies. Nephrol Dial Transplant 2004, 19:1347-1351 (Pubitemid 38786719)
11. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3:research0034.1-34.11
12. Hui ABY, Shi W, Boutros PC, Miller N, Pintilie M, Fyles T, McCready D, Wong D, Gerster K, Jurisica I, Penn LZ, Liu FF: Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab Invest 2009, 89:597-606
13. Best DJ, Roberts DE: Algorithm AS 89: upper tail probabilities of Spearman's Rho. Applied Statistics 1974, 24:377-379
14. Boutros PC, Yan R, Moffat ID, Pohjanvirta R, Okey AB: Transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in liver: comparison of rat and mouse. BMC Genomics 2008, 9:419
15. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M: The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004, 15:241-250 (Pubitemid 38140764)
16. Henger A, Kretzler M, Doran P, Bonrouhi M, Schmid H, Kiss E, Cohen CD, Madden S, Porubsky S, Grone EF, Schlondorff D, Nelson PJ, Grone HJ: Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression. Kidney Int 2004, 65:904-917 (Pubitemid 38251066)
17. Schmid H, Boucherot A, Yasuda Y, Henger A, Brunner B, Eichinger F, Nitsche A, Kiss E, Bleich M, Grone HJ, Nelson PJ, Schlondorff D, Cohen CD, Kretzler M: Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 2006, 55:2993-3003 (Pubitemid 44923635)
18. Rudnicki M, Eder S, Perco P, Enrich J, Scheiber K, Koppelstatter C, Schratzberger G, Mayer B, Oberbauer R, Meyer TW, Mayer G: Gene expression profiles of human proximal tubular epithelial cells in proteinuric nephropathies. Kidney Int 2007, 71:325-335 (Pubitemid 46227092)
19. O'Shaughnessy JA: Molecular signatures predict outcomes of breast cancer. N Engl J Med 2006, 355:615-617
20. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J, Reich M, Chan JA, Glickman JN, Ikeda K, Hashimoto M, Watanabe G, Daidone MG, Roayaie S, Schwartz M, Thung S, Salvesen HB, Gabriel S, Mazzaferro V, Bruix J, Friedman SL, Kumada H, Llovet JM, Golub TR: Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 2008, 359:1995-2004
21. Ricardo SD, van Goor H, Eddy AA: Macrophage diversity in renal injury and repair. J Clin Invest 2008, 118:3522-3530
22. Liu Y: New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 2010, 21:212-222
23. Kalluri R, Neilson EG: Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003, 112:1776-1784 (Pubitemid 38063698)
24. Anders HJ, Belemezova E, Eis V, Segerer S, Vielhauer V, Perez de Lema G, Kretzler M, Cohen CD, Frink M, Horuk R, Hudkins KL, Alpers CE, Mampaso F, Schlondorff D: Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice. J Am Soc Nephrol 2004, 15:1504-1513 (Pubitemid 38679675)
25. Mezzano SA, Ruiz-Ortega M, Egido J: Angiotensin II and renal fibrosis. Hypertension 2001, 38:635-638
26. Lenz O, Elliot SJ, Stetler-Stevenson WG: Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol 2000, 11:574-581 (Pubitemid 30115088)
27. Peterson KS, Huang JF, Zhu J, D'Agati V, Liu X, Miller N, Erlander MG, Jackson MR, Winchester RJ: Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J Clin Invest 2004, 113:1722-1733 (Pubitemid 39071664)
28. Fisher DA, Salido EC, Barajas L: Epidermal growth factor and the kidney. Annu Rev Physiol 1989, 51:67-80 (Pubitemid 19088308)
29. Gilbert RE, Cox A, McNally PG, Wu LL, Dziadek M, Cooper ME, Jerums G: Increased epidermal growth factor in experimental diabetes related kidney growth in rats. Diabetologia 1997, 40:778-785 (Pubitemid 27306955)
30. Teteris SA, Menahem SA, Perry G, Maguire JA, Dowling JP, Langham RG, Thomson NM, Stein AN: Dysregulated growth factor gene expression is associated with tubulointerstitial apoptosis and renal dysfunction. Kidney Int 2007, 71:1044-1053 (Pubitemid 46741988)
31. Ferraccioli G, Romano G: Renal interstitial cells, proteinuria and progression of lupus nephritis: new frontiers for old factors. Lupus 2008, 17:533-540 (Pubitemid 351955428)
32. Mathiesen ER, Nexo E, Hommel E, Parving HH: Reduced urinary excretion of epidermal growth factor in incipient and overt diabetic nephropathy. Diabet Med 1989, 6:121-126 (Pubitemid 19058810)
33. Torres DD, Rossini M, Manno C, Mattace-Raso F, D'Altri C, Ranieri E, Pontrelli P, Grandaliano G, Gesualdo L, Schena FP: The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. Kidney Int 2008, 73:327-333
34. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 1998, 339:1448-1456 (Pubitemid 28516069)
35. Schainuck LI, Striker GE, Cutler RE, Benditt EP: Structural-functional correlations in renal disease. II. The correlations. Hum Pathol 1970, 1:631-641
36. Rodriguez-Iturbe B, Johnson RJ, Herrera-Acosta J: Tubulointerstitial damage and progression of renal failure. Kidney Int 2005, 68(Suppl 99)S82-S86
37. Gilbert RE, Cooper ME: The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 1999, 56:1627-1637